Literature DB >> 11960541

Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications.

Nicholas Shaheen1, David F Ransohoff.   

Abstract

Gastroesophageal reflux disease (GERD), a condition commonly encountered in the primary care setting, is a risk factor for adenocarcinoma of the esophagus. Despite the ubiquity of the complaint, considerable uncertainty exists with respect to several basic questions, including when to perform endoscopy in patients with chronic reflux symptoms and how to address the cancer risk associated with GERD. These clinical vignettes illustrate common clinical questions encountered in caring for patients with GERD, especially as they relate to the issue of cancer risk. Applying data reviewed in the companion article, we propose practical answers to common clinical situations regarding care of patients with reflux. We also present an algorithm for treatment of patients with chronic GERD symptoms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960541     DOI: 10.1001/jama.287.15.1982

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  27 in total

1.  Diallyl Disulfide Suppresses the Inflammation and Apoptosis Resistance Induced by DCA Through ROS and the NF-κB Signaling Pathway in Human Barrett's Epithelial Cells.

Authors:  Cheng Feng; Yumei Luo; Yuanyuan Nian; Dong Liu; Xiaoran Yin; Jing Wu; Jia Di; Rong Zhang; Jun Zhang
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

2.  Influence of age on outcome of total laparoscopic fundoplication for gastroesophageal reflux disease.

Authors:  F Pizza; G Rossetti; P Limongelli; G Del Genio; V Maffettone; V Napolitano; L Brusciano; G Russo; S Tolone; M Di Martino; A Del Genio
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  Gastroesophageal reflux disease and physical activity.

Authors:  Pawel Jozkow; Dorota Wasko-Czopnik; Marek Medras; Leszek Paradowski
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 4.  Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesis.

Authors:  Gen Kusaka; Kaname Uno; Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 5.  Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.

Authors:  Liying Yang; Fritz Francois; Zhiheng Pei
Journal:  Clin Cancer Res       Date:  2012-02-16       Impact factor: 12.531

6.  Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins.

Authors:  Zongli Zheng; Helena Nordenstedt; Nancy L Pedersen; Jesper Lagergren; Weimin Ye
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

7.  Predicting Neoplastic Progression in Barrett's Esophagus.

Authors:  Jean S Wang; Marcia I Canto
Journal:  Ann Gastroentol Hepatol       Date:  2010-06

8.  Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.

Authors:  Zheng Chen; Rama Saad; Peilin Jia; DunFa Peng; Shoumin Zhu; M Kay Washington; Zhongming Zhao; Zekuan Xu; Wael El-Rifai
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

Review 9.  Body weight, lifestyle, dietary habits and gastroesophageal reflux disease.

Authors:  Davide Festi; Eleonora Scaioli; Fabio Baldi; Amanda Vestito; Francesca Pasqui; Anna Rita Di Biase; Antonio Colecchia
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

10.  DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus.

Authors:  Jean S Wang; Mingzhou Guo; Elizabeth A Montgomery; Richard E Thompson; Hilary Cosby; Lisa Hicks; Shelun Wang; James G Herman; Marcia I Canto
Journal:  Am J Gastroenterol       Date:  2009-07-07       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.